Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-01-30Clinical Trial Update: Randomised Study Comparing Three Chemotherapy Regimens in Non-small Cell Lung Cancer [Phase 3]
A Phase 3 randomized trial comparing three chemotherapy regimens in non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-01-30Clinical Trial Update: Regimen for the Treatment of Cachexia in Subjects With NSCLC [Phase 2]
Phase 2 clinical trial evaluating a regimen for treating cachexia in subjects with non-small cell lung cancer; results were posted in 2013 a…
-
CLINICAL_TRIALS trial_result · 2013-01-29Clinical Trial Update: Phase II Trial of Erlotinib and Concurrent Palliative Thoracic Radiation Therapy for Non-small Cell Lung Cancer (PEARL) [Phase 2]
Clinical trial PEARL is a Phase II study evaluating erlotinib with concurrent palliative thoracic radiation therapy for non-small cell lung …
-
CLINICAL_TRIALS trial_result · 2013-01-29Clinical Trial Update: First Line Gefitinib by FDG-PET Metabolic Response [Phase 2]
This clinical trial update describes a Phase 2 study evaluating first-line gefitinib in non-small cell lung cancer guided by FDG-PET metabol…
-
CLINICAL_TRIALS trial_result · 2013-01-29Clinical Trial Update: Paclitaxel/Carboplatin (PC) Followed by Gefitinib Versus PC in Advanced Non-small Cell Lung Cancer [Phase 2]
A Phase 2 randomized trial in advanced non-small cell lung cancer compares paclitaxel/carboplatin followed by gefitinib versus paclitaxel/ca…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2013-01-29Clinical Trial Update: Maintenance ZD1839 (IRESSA®) Following Completion of Front Line, Platinum-Based, Double Chemotherapy in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer [Phase 3]
A phase 3 trial evaluating maintenance IRESSA (gefitinib) after front-line platinum-based chemotherapy in advanced or metastatic non-small c…
-
CLINICAL_TRIALS trial_result · 2013-01-29Clinical Trial Update: Study of M2ES With Paclitaxel/Carboplatin (TC Regimen) in Advanced Non Small Cell Lung Cancer (NSCLC) [NA]
This entry reports the completion of a clinical trial evaluating M2ES with paclitaxel and carboplatin (the TC regimen) for advanced non-smal…
-
CLINICAL_TRIALS research · 2013-01-28Clinical Trial Update: Evaluation of EGFR TKI Resistance Mechanism Using Plasma DNA Analysis [NA]
This clinical trial update describes evaluating EGFR TKI resistance mechanisms in EGFR-mutant non-small cell lung cancer using plasma DNA an…
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: Study to Evaluate SID 530 Compared to Taxotere [Phase 3]
Phase 3 study evaluating SID 530 versus Taxotere in non-small cell lung cancer has completed. The trial evaluated efficacy and safety outcom…
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: GTI-2040 and Docetaxel in Treating Patients With Recurrent, Metastatic, or Unresectable Locally Advanced Non-Small Cell Lung Cancer, Prostate Cancer, or Other Solid Tumors [Phase 1, Phase 2]
Phase 1/2 trial evaluating GTI-2040 with docetaxel in patients with recurrent/metastatic non-small cell lung cancer or prostate cancer; the …
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: Bortezomib Plus Gemcitabine and Carboplatin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer [Phase 1]
This Phase 1 study assessed the safety and preliminary activity of combining bortezomib with gemcitabine and carboplatin in patients with ad…
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: Combination Chemotherapy Plus Radiation Therapy With or Without AE-941 in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed By Surgery [Phase 3]
A Phase 3 trial evaluating whether adding AE-941 to combination chemotherapy and radiation improves outcomes for patients with stage III non…
-
CLINICAL_TRIALS trial_result · 2013-01-21Clinical Trial Update: PET/CT Imaging for Radiation Dosimetry, Plasma Pharmacokinetics, Safety and Tolerability in Healthy Volunteers and Safety, Tolerability and Diagnostic Performance of BAY86-9596 in Patients With Non-small Cell Lung Cancer, Breast Cancer, Head and Neck Cancer and Patients With Inflammations [Phase 1]
Phase 1 trial results evaluate BAY86-9596 as a PET tracer for diagnostic imaging across cancer and inflammatory conditions. The study report…
-
CLINICAL_TRIALS trial_result · 2013-01-18Clinical Trial Update: A Phase II Trial of Genexol-PM and Gemcitabine in Patients With Advanced Non-small-cell Lung Cancer [Phase 2]
A Phase II trial evaluating Genexol-PM in combination with Gemcitabine for advanced non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-01-18Clinical Trial Update: Evaluation of Preoperative Endobronchial Ultrasound (EBUS) in Non Small Cell Lung Cancer (NSCLC)
This clinical trial update notes the completion of a study evaluating preoperative endobronchial ultrasound (EBUS) in non-small cell lung ca…
-
CLINICAL_TRIALS trial_result · 2013-01-17Clinical Trial Update: Radiation Therapy, Bevacizumab, Paclitaxel, and Carboplatin in Treating Patients With Unresectable Stage IIIB or Stage IV Non-Small Cell Lung Cancer at High Risk for Hemoptysis Caused by Bevacizumab [Phase 2]
This Phase 2 trial evaluated a regimen of radiation therapy with bevacizumab, paclitaxel, and carboplatin in patients with unresectable Stag…
-
CLINICAL_TRIALS trial_result · 2013-01-17Clinical Trial Update: Vorinostat in Combination With Palliative Radiotherapy for Patients With Non-Small Cell Lung Cancer [Phase 1]
Phase 1 clinical trial evaluating vorinostat in combination with palliative radiotherapy for non-small cell lung cancer has completed with r…
-
CLINICAL_TRIALS trial_result · 2013-01-16Clinical Trial Update: A Study of Continuous Endostar Intravenous Infusion Combined With Pemetrexed and Carboplatin in Advanced Non Small Cell Lung Cancer Patients [Phase 1]
Phase 1 trial evaluating the safety and tolerability of a continuous intravenous infusion of Endostar combined with pemetrexed and carboplat…
-
CLINICAL_TRIALS trial_result · 2013-01-16Clinical Trial Update: Bortezomib in Treating Patients With Advanced Non-small Cell Lung Cancer [Phase 2]
Phase 2 trial of Bortezomib in patients with advanced non-small cell lung cancer was terminated. The update notes the trial status and the c…
-
CLINICAL_TRIALS trial_result · 2013-01-16Clinical Trial Update: Trastuzumab in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer That Overexpresses HER2 [Phase 2]
A Phase 2 trial evaluated trastuzumab for HER2-overexpressing stage IIIB or stage IV non-small cell lung cancer; the study status is complet…
-
CLINICAL_TRIALS trial_result · 2013-01-16Clinical Trial Update: EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer [NA]
This NCI-sponsored clinical trial evaluating EF5 and Motexafin Lutetium for detecting tumor cells in patients with abdominal cancers or non-…
-
CLINICAL_TRIALS trial_result · 2013-01-15Clinical Trial Update: Pemetrexed Disodium, Carboplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Stage III Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating pemetrexed disodium with carboplatin and radiation therapy, with or without cetuximab, in stage III non-small cell …
-
CLINICAL_TRIALS trial_result · 2013-01-15Clinical Trial Update: PET Imaging in Potentially Surgically Resectable Non-small Cell Lung Cancers [Phase 3]
This document reports on a completed Phase 3 trial evaluating PET imaging in potentially surgically resectable non-small cell lung cancer. I…
-
CLINICAL_TRIALS trial_result · 2013-01-15Clinical Trial Update: Comparison of Sequencing and PNA Clamping of EGFR Gene in Patients With Non-Small Cell Type Lung Cancer
This clinical trial update compares sequencing and PNA clamping methods for EGFR gene testing in patients with non-small cell lung cancer, s…
-
CLINICAL_TRIALS trial_result · 2013-01-14Clinical Trial Update: Erlotinib Is Being Studied With Or Without An Investigational Drug, PF-02341066, In Patients With Lung Cancer [Phase 1]
Pfizer conducted a Phase 1 trial of erlotinib with or without the investigational agent PF-02341066 in patients with non-small cell lung can…